Basic Information
| LncRNA/CircRNA Name | CACS15 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | oral squamous cell carcinoma |
| ICD-0-3 | C06.9 |
| Methods | qPCR etc. |
| Sample | oral squamous cell carcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | CASC15 over-expression may serve as a potential diagnostic biomarker for oral squamous cell carcinoma and CASC15 may promote oral squamous cell carcinoma cell proliferation by down-regulating MEG3 |
| Pubmed ID | 31793142 |
| Year | 2019 |
| Title | Up-regulation of Plasma lncRNA CACS15 Distinguished Early-Stage Oral Squamous Cell Carcinoma Patient |
External Links
| Links for CACS15 | GenBank HGNC NONCODE |
| Links for oral squamous cell carcinoma | OMIM COSMIC |